Click here to take the CME Evaluation and Post-Meeting Survey
David "Davey" M. Smith is an American translational research virologist, Chief of the Division of Infectious Diseases and Global Public Health at the University of California San Diego (UC San Diego), Co-Director of the San Diego Center for AIDS Research (SD CFAR), and Vice-Chair of Research in the Department of Medicine at UC San Diego. His research interests include transmission, prevention, and treatment of both HIV and SARS-CoV2 (COVID-19). Since joining the UC San Diego faculty in 2003, Smith has been awarded more than $37 million in federal funding as a Principal Investigator. His research interests include transmission, prevention, and treatment of both HIV and SARS-CoV2 (COVID-19). Dr. Smith did his residency in Internal Medicine and his fellowship in infectious Disease at UCSD, where he then stayed to join the faculty. He serves as Co-Director of San Diego CFAR, Vice-Chair of Research, and Head of the UCSD Division of Infectious Diseases and Global Public Health.
At the completion of this program, participants will have a better understanding of:
1. The natural history of COVID-19.
2. Monoclonal antibody therapies and their indications under an EUA.
3. Other antiviral therapies under investigation.
This CME activity has approved for AMA PRA Category 1 Credit™
for May 12, 2021 as a live activity. This activity will also be available as an enduring activity from May 13, 2021, through May 11, 2024.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.
- Dr. James F. Braun, DO (Course Director) has no relevant financial relationships to disclose.
- Dr. William M. Valenti (Moderator) has no relevant financial relationships to disclose.
- Dr. David M. Smith (Presenter) has no relevant financial relationships to disclose. Dr. Smith will support his presentation and clinical recommendations with the best available evidence from the medical literature and will submit his slides in advance for adequate peer review.
This PRN CME activity is funded in part by unrestricted educational grants from:
Click here to take the CME Evaluation and Post-Meeting Evaluation
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare